Organization: PainCeptor Pharma Corp

PainCeptor receives IRAP assistance

PainCeptor Pharma Corp has received $480,000 in funding from the Industrial Research Assistance Program to further develop its drug development program for pain-related conditions such as arthritis and cancer. The contribution agreement will be used to advance PainCeptor’s R&D for the design and synthesis of low molecular weight compounds as part of its ASIC 3…